IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v52y2000i3p157-169.html
   My bibliography  Save this article

Importing budget systems from other countries: what can we learn from the German drug budget and the British GP fundholding?

Author

Listed:
  • Delnoij, Diana
  • Brenner, Gerhard

Abstract

No abstract is available for this item.

Suggested Citation

  • Delnoij, Diana & Brenner, Gerhard, 2000. "Importing budget systems from other countries: what can we learn from the German drug budget and the British GP fundholding?," Health Policy, Elsevier, vol. 52(3), pages 157-169, July.
    • Handle: RePEc:eee:hepoli:v:52:y:2000:i:3:p:157-169
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0168-8510(00)00074-9
    Download Restriction: Full text for ScienceDirect subscribers only
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Saltman, Richard B., 1997. "The context for health reform in the United Kingdom, Sweden, Germany, and the United States," Health Policy, Elsevier, vol. 41(Supplemen), pages 9-26, September.
    2. Vohlonen, Ilkka & Pekurinen, Markku & Saltman, Richard B., 1989. "Re-organizing primary medical care in Finland: The personal doctor program," Health Policy, Elsevier, vol. 13(1), pages 65-79, October.
    3. Gosden, Toby & Torgerson, David J., 1997. "The effect of fundholding on prescribing and referral costs: a review of the evidence," Health Policy, Elsevier, vol. 40(2), pages 103-114, May.
    4. von der Schulenburg, J. -Matthias Graf, 1997. "Management of cost and utilization of pharmaceuticals in Germany," Health Policy, Elsevier, vol. 41(Supplemen), pages 45-53, September.
    5. Schöffski, Oliver & von der Schulenburg, J. Matthias Graf, 1997. "Unintended effects of a cost-containment policy: Results of a natural experiment in Germany," Social Science & Medicine, Elsevier, vol. 45(10), pages 1537-1539, November.
    6. Wilson, Robert P. H. & Hatcher, Juanita & Barton, Stuart & Walley, Tom, 1997. "General practice fundholders' prescribing savings in one region of the United Kingdom, 1991-1994," Health Policy, Elsevier, vol. 42(1), pages 29-37, October.
    7. Kamke, Kerstin, 1998. "The German health care system and health care reform," Health Policy, Elsevier, vol. 43(2), pages 171-194, February.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Steve Morgan & Jamie R. Daw & Michael R. Law, 2013. "Rethinking Pharmacare in Canada," C.D. Howe Institute Commentary, C.D. Howe Institute, issue 384, June.
    2. Riise, Julie & Hole, Arne Risa & Gyrd-Hansen, Dorte & Skåtun, Diane, 2016. "GPs' implicit prioritization through clinical choices – evidence from three national health services," Journal of Health Economics, Elsevier, vol. 49(C), pages 169-183.
    3. Bergstrom, Gina & Karlberg, Ingvar, 2007. "Decentralized responsibility for costs of outpatient prescription pharmaceuticals in Sweden: Assessment of models for decentralized financing of subsidies from a management perspective," Health Policy, Elsevier, vol. 81(2-3), pages 358-367, May.
    4. Kwon, Hye-Young & Bae, Seungjin & Choi, Sang-eun & Park, Sylvia & Lee, Eui-Kyung & Park, Sungmin & Kim, Jinhyun, 2019. "Easy cuts, easy rebound: Drug expenditures with massive price cuts in Korea," Health Policy, Elsevier, vol. 123(4), pages 388-392.
    5. Kwon, Hye-Young & Hong, Ji-Min & Godman, Brian & Yang, Bong-Min, 2013. "Price cuts and drug spending in South Korea: The case of antihyperlipidemic agents," Health Policy, Elsevier, vol. 112(3), pages 217-226.
    6. Park, Sun-Young & Han, Euna & Kim, Jini & Lee, Eui-Kyung, 2016. "Factors influencing the difference between forecasted and actual drug sales volumes under the price–volume agreement in South Korea," Health Policy, Elsevier, vol. 120(8), pages 867-874.
    7. Yue-Chune Lee & Ming-Chin Yang & Yu-Tung Huang & Chien-Hsiang Liu & Sun-Bing Chen, 2006. "Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996–2003," PharmacoEconomics, Springer, vol. 24(9), pages 891-902, September.
    8. Ruof, Jorg & Mittendorf, Thomas & Pirk, Olaf & Graf von der Schulenburg, J. -Matthias, 2002. "Diffusion of innovations: treatment of Alzheimer's disease in Germany," Health Policy, Elsevier, vol. 60(1), pages 59-66, April.
    9. Kim Olsen & Dorte Gyrd-Hansen & Andreas Boegh & Sofie Hansen, 2009. "GPs as citizens’ agents: prescription behavior and altruism," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(4), pages 399-407, October.
    10. Gorecki, Paul K. & Nolan, Anne & Brick, Aoife & Lyons, Seán, 2012. "Pharmaceuticals Delivery in Ireland. Getting a Bigger Bang for the Buck," Research Series, Economic and Social Research Institute (ESRI), number RS24, June.
    11. Paraponaris, A. & Verger, P. & Desquins, B. & Villani, P. & Bouvenot, G. & Rochaix, L. & Gourheux, J. C. & Moatti, J. P. AU -, 2004. "Delivering generics without regulatory incentives?: Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names," Health Policy, Elsevier, vol. 70(1), pages 23-32, October.
    12. Whynes, David K. & Baines, Darrin L., 2002. "Primary care physicians' attitudes to health care reform in England," Health Policy, Elsevier, vol. 60(2), pages 111-132, May.
    13. Lesley Tilson & Kathleen Bennett & Michael Barry, 2005. "The potential impact of implementing a system of generic substitution on the community drug schemes in Ireland," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(3), pages 267-273, September.
    14. Hayen, A.P. & van den Berg, M.J. & Meijboom, B.R. & Struijs, J.N. & Westert, G.P., 2015. "Incorporating shared savings programs into primary care : From theory to practice," Other publications TiSEM 2e26be96-1dc3-41fe-8dc9-c, Tilburg University, School of Economics and Management.
    15. Brick, Aoife & Gorecki, Paul K. & Nolan, Anne, 2013. "Ireland: Pharmaceutical Prices, Prescribing Practices and Usage of Generics in a Comparative Context," Research Series, Economic and Social Research Institute (ESRI), number RS32, June.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Paraponaris, A. & Verger, P. & Desquins, B. & Villani, P. & Bouvenot, G. & Rochaix, L. & Gourheux, J. C. & Moatti, J. P. AU -, 2004. "Delivering generics without regulatory incentives?: Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names," Health Policy, Elsevier, vol. 70(1), pages 23-32, October.
    2. Bergstrom, Gina & Karlberg, Ingvar, 2007. "Decentralized responsibility for costs of outpatient prescription pharmaceuticals in Sweden: Assessment of models for decentralized financing of subsidies from a management perspective," Health Policy, Elsevier, vol. 81(2-3), pages 358-367, May.
    3. Katharina Elisabeth Fischer & Taika Koch & Karel Kostev & Tom Stargardt, 2018. "The impact of physician-level drug budgets on prescribing behavior," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(2), pages 213-222, March.
    4. Claudia Pütz & Christian Hagist, 2006. "Optional deductibles in social health insurance systems," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 7(4), pages 225-230, December.
    5. Claus Wendt, 1999. "Health Services for Children in Denmark, Germany, Austria and Great Britain," MZES Working Papers 4, MZES.
    6. Hamdan, Motasem & Defever, Mia, 2002. "A `transitional' context for health policy development: the Palestinian case," Health Policy, Elsevier, vol. 59(3), pages 193-207, March.
    7. Schneeweiss, Sebastian & Schoffski, Oliver & Selke, Gisbert W, 1998. "What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?," Health Policy, Elsevier, vol. 44(3), pages 253-260, June.
    8. Shin, Young-Jeon, 2006. "Policy context of the poor progress of the pro-poor policy: A case study on the Medical-Aid policy during Kim Dae-jung's Government (1998-2002) in the Republic of Korea," Health Policy, Elsevier, vol. 78(2-3), pages 209-223, October.
    9. Milne, Robin G. & Torsney, Ben, 2003. "Financial incentives, competition and a two tier service: lessons from the UK National Health Service internal market," Health Policy, Elsevier, vol. 64(1), pages 1-12, April.
    10. Schreyögg, Jonas & Henke, Klaus-Dirk & Busse, Reinhard, 2004. "Managing pharmaceutical regulation in Germany: Overview and economic assessment," Discussion Papers 2004/6, Technische Universität Berlin, School of Economics and Management.
    11. Gosden, Toby & Sibbald, Bonnie & Williams, Jackie & Petchey, Roland & Leese, Brenda, 2003. "Paying doctors by salary: a controlled study of general practitioner behaviour in England," Health Policy, Elsevier, vol. 64(3), pages 415-423, June.
    12. Whynes, David K. & Baines, Darrin L., 2002. "Primary care physicians' attitudes to health care reform in England," Health Policy, Elsevier, vol. 60(2), pages 111-132, May.
    13. Mark Dusheiko & Hugh Gravelle & Rowena Jacobs & Peter C Smith, "undated". "The Effect of Budgets on Doctor Behaviour: Evidence From A Natural Experiment," Discussion Papers 03/04, Department of Economics, University of York.
    14. Waters, Hugh R. & Hussey, Peter, 2004. "Pricing health services for purchasers--a review of methods and experiences," Health Policy, Elsevier, vol. 70(2), pages 175-184, November.
    15. Lurås, Hilde, 2009. "General Practice: Four Empirical Essays on GP Behaviour and Individuals’ Preferences for GPs," HERO Online Working Paper Series 2004:1, University of Oslo, Health Economics Research Programme.
    16. Lambrelli, Dimitra & O'Donnell, Owen, 2011. "The impotence of price controls: Failed attempts to constrain pharmaceutical expenditures in Greece," Health Policy, Elsevier, vol. 101(2), pages 162-171, July.
    17. Jonathan Skinner & John E. Wennberg, 2000. "Regional Inequality in Medicare Spending: The Key to Medicare Reform?," NBER Chapters, in: Frontiers in Health Policy Research, Volume 3, pages 69-90, National Bureau of Economic Research, Inc.
    18. Stargardt, Tom & Schreyögg, Jonas & Busse, Reinhard, 2007. "Pricing behaviour of pharmacies after market deregulation for OTC drugs: The case of Germany," Health Policy, Elsevier, vol. 84(1), pages 30-38, November.
    19. Garattini, Livio & Tediosi, Fabrizio, 2000. "A comparative analysis of generics markets in five European countries," Health Policy, Elsevier, vol. 51(3), pages 149-162, April.
    20. Mossialos, Elias & Mrazek, Monique F., 2003. "The regulation of pharmacies in six countries: report prepared for the Office of Fair Trading," LSE Research Online Documents on Economics 22505, London School of Economics and Political Science, LSE Library.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:52:y:2000:i:3:p:157-169. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.